Ah Equity Partners Bio Ii, L.L.C 13F annual report
Ah Equity Partners Bio Ii, L.L.C is an investment fund managing more than $142 million ran by Scott Kupor. There are currently 4 companies in Mr. Kupor’s portfolio. The largest investments include Eqrx, Inc. and Nautilus Biotechnology, Inc., together worth $126 million.
$142 million Assets Under Management (AUM)
As of 8th August 2022, Ah Equity Partners Bio Ii, L.L.C’s top holding is 17,438,465 shares of Eqrx, Inc. currently worth over $81.8 million and making up 57.4% of the portfolio value.
In addition, the fund holds 16,298,006 shares of Nautilus Biotechnology, Inc. worth $43.8 million.
The third-largest holding is Erasca, Inc. worth $13.9 million and the next is Invitae Corp worth $2.86 million, with 1,170,127 shares owned.
Currently, Ah Equity Partners Bio Ii, L.L.C's portfolio is worth at least $142 million. The total portfolio value may be much higher due to cash
assets that are not publicly disclosed such as fixed income, real estate, or cash equivalents.
Careers at Ah Equity Partners Bio Ii, L.L.C
The Ah Equity Partners Bio Ii, L.L.C office and employees reside in Menlo Park, California. According to the last 13-F report filed with the SEC, Scott Kupor serves as the Chief Operating Officer at Ah Equity Partners Bio Ii, L.L.C.
One of the smallest hedge funds
The two most similar investment funds to Ah Equity Partners Bio Ii, L.L.C are Reliant Investment Management and Tacita Capital Inc. They manage $142 million and $142 million respectively.
Scott Kupor investment strategy
Ah Equity Partners Bio Ii, L.L.C’s portfolio is diversified across 2 sectors.
Currently, their heaviest sector is Health Care — making up 2.0% of
the total portfolio value.
The fund focuses on investments in the United States as
25.0% of the portfolio companies
are based in the United States.
The majority of the companies in the fund’s portfolio are large-cap stocks.
Stocks with a size of more than $10 billion in market cap make up
approximately 0.1% of the total holdings value.
On the other hand, small-cap stocks make up only approximately 0.1% of the portfolio.
The average market cap of the portfolio companies is close to $1.22 billion.
The complete list of Ah Equity Partners Bio Ii, L.L.C trades based on 13F SEC filings
These positions were updated on August 15th based on the fund’s latest 13F filing. Quickly find out what the most recently closed or increased positions are.
| Security | Shares Owned | Value | Allocation |
|---|---|---|---|
| Eqrx, Inc. |
No change
17,438,465
|
$81,786,000 | 57.43% |
| Nautilus Biotechnology, Inc. |
No change
16,298,006
|
$43,842,000 | 30.79% |
| Erasca, Inc. |
No change
2,500,000
|
$13,925,000 | 9.78% |
| Invitae Corp |
No change
1,170,127
|
$2,855,000 | 2.00% |
| No transactions found | |||
| Showing first 500 out of 4 holdings | |||
Hedge funds similar to Ah Equity Partners Bio Ii, L.L.C
- Frontier Asset Management
- Solitude Services
- Lfa - Lugano Advisors S.A.
- Mach-1
- 1776 Wealth
- First Growth Capital Management
- Tacita Capital Inc
- Reliant Investment Management
- Afg Fiduciary Services Limited Partnership
- Smart Money
- Investment Counsel
- Laurel Wealth Planning
- Clarus Wealth Advisors
- Heronetta Management, L.P.